Bluejay Diagnostics
BJDX
5 hedge funds and large institutions have $119K invested in Bluejay Diagnostics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.
74.8% more ownership
Funds ownership: 34.57% → 109.37% (+75%)
29% less funds holding
Funds holding: 7 → 5 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
66% less capital invested
Capital invested by funds: $345K → $119K (-$226K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$292K |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$278K |
| 3 |
VF
Virtu Financial
New York
|
+$65.5K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$52.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$15.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$150K |
| 2 |
AC
Armistice Capital
New York
|
-$141K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$15.9K |
| 4 |
Renaissance Technologies
New York
|
-$14K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$8.43K |
BJDX Hedge Fund Activity: Q2 2024 in Review
5 of the 6,936 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q2 2024, worth a combined $119K — down 66% from $345K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of BJDX and 3 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $292K. The largest seller was Sabby Management, exiting entirely with an estimated $150K sold.
- 5 institutional investors held Bluejay Diagnostics (BJDX) as of Q2 2024, down from 7 in Q1 2024.
- Funds reported $119K of Bluejay Diagnostics stock for Q2 2024, down 66% quarter-over-quarter.
- 3 funds opened new Bluejay Diagnostics positions in Q2 2024 and 5 closed out, a net change of -2 holders.
- The largest Bluejay Diagnostics buyer in Q2 2024 was Anson Funds Management, an estimated $292K added.
- The largest Bluejay Diagnostics seller in Q2 2024 was Sabby Management, an estimated $150K sold.
Based on aggregated 13F filings for Q2 2024.